What is 4D Molecular Therapeutics's JP — revenue?

4D Molecular Therapeutics (FDMT) reported JP — revenue of $2.96M in Q1 2026.

What does JP — revenue mean?

This metric represents the total gross income generated from the company's operations within the designated geographic or business segment. It reflects the commercial success and market penetration of the company's product portfolio, specifically including gene therapy candidates, within this specific region. Tracking this revenue stream is essential for evaluating the geographic diversification of the company's clinical-stage pipeline and its ability to monetize therapeutic assets in key markets.

4D Molecular Therapeutics FDMT JP — Revenue

Other geography segments

$90K+543%

Similar metrics at other companies

NUVBJP — Revenue

$652K+256%

KDJP — Revenue

$571M-3.1%

ORCLJP — Revenue

$467.5M+6.3%

THRMJP — Revenue

$11.88M-1.8%

OLEDJP — Revenue

$371K-10.2%

HAEJP — Revenue

$18.14M+12.1%

Other financials

Income statement

See full

Revenue$3.0M+21,664%

Operating income-$73.6M-37.3%

Net income-$68.8M-43.3%

EPS (diluted)-$1.01-17.4%

Balance sheet

See full

Cash & equivalents$72.5M-45.7%

Total debt$20.5M-13.9%

Total equity$451.8M-3.8%

Total assets$512.9M-0.5%

Cash flow

See full

Operating cash flow-$68.1M-42.6%

CapEx--100%

Free cash flow-$68.1M-40.8%

Valuation

See full

Market cap$602.22M+215%

Enterprise value$550.27M+574%

P/S6.8×-8,306×

Profitability

See full

Operating margin-220.1%-110pp

Net margin-174,314.2%-62,763pp

FCF margin-154,209.2%-53,057pp

Returns & leverage

See full

Return on equity-45.4%+29.8pp

Debt / equity0×0.0×

Current ratio9.3×-3.0×

Where this comes from

Reported directly by 4D Molecular Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: 4D Molecular Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about 4D Molecular Therapeutics's jp — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is 4D Molecular Therapeutics's JP — revenue?: 4D Molecular Therapeutics (FDMT) reported JP — revenue of $2.96M in Q1 2026.
What does JP — revenue mean?: This metric represents the total gross income generated from the company's operations within the designated geographic or business segment. It reflects the commercial success and market penetration of the company's product portfolio, specifically including gene therapy candidates, within this specific region. Tracking this revenue stream is essential for evaluating the geographic diversification of the company's clinical-stage pipeline and its ability to monetize therapeutic assets in key markets.